Search

Mary M. Lyons

Examiner (ID: 4587, Phone: (571)272-2966 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1645, 1653
Total Applications
674
Issued Applications
377
Pending Applications
90
Abandoned Applications
228

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16557184 [patent_doc_number] => 20210002332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => SYSTEMS AND METHODS FOR FORMING BIOLOGICAL NANOWIRES AND APPLICATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 16/976971 [patent_app_country] => US [patent_app_date] => 2019-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7600 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -48 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16976971 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/976971
SYSTEMS AND METHODS FOR FORMING BIOLOGICAL NANOWIRES AND APPLICATIONS THEREOF Feb 28, 2019 Issued
Array ( [id] => 14435693 [patent_doc_number] => 20190175718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-13 [patent_title] => NEISSERIA MENINGITIDIS VACCINE [patent_app_type] => utility [patent_app_number] => 16/282080 [patent_app_country] => US [patent_app_date] => 2019-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29399 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -98 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16282080 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/282080
None Feb 20, 2019 Issued
Array ( [id] => 15055363 [patent_doc_number] => 10457973 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-29 [patent_title] => Method for rapidly determining effective sterilization, deimmunization, and/or disinfection [patent_app_type] => utility [patent_app_number] => 16/275721 [patent_app_country] => US [patent_app_date] => 2019-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 22 [patent_no_of_words] => 19878 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16275721 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/275721
Method for rapidly determining effective sterilization, deimmunization, and/or disinfection Feb 13, 2019 Issued
Array ( [id] => 16629021 [patent_doc_number] => 20210047674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-18 [patent_title] => SAMPLING OF MICROORGANISMS [patent_app_type] => utility [patent_app_number] => 16/967876 [patent_app_country] => US [patent_app_date] => 2019-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5957 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967876 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/967876
Sampling of microorganisms Feb 7, 2019 Issued
Array ( [id] => 18619311 [patent_doc_number] => 11752335 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-09-12 [patent_title] => Method for determining facial muscle responses [patent_app_type] => utility [patent_app_number] => 16/270211 [patent_app_country] => US [patent_app_date] => 2019-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 10022 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16270211 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/270211
Method for determining facial muscle responses Feb 6, 2019 Issued
Array ( [id] => 15978507 [patent_doc_number] => 10669563 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-02 [patent_title] => Method for the production of protein complexes and vaccine compositions comprising the same [patent_app_type] => utility [patent_app_number] => 16/270406 [patent_app_country] => US [patent_app_date] => 2019-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11119 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16270406 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/270406
Method for the production of protein complexes and vaccine compositions comprising the same Feb 6, 2019 Issued
Array ( [id] => 14655609 [patent_doc_number] => 20190234933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => COMPOSITIONS AND ASSAYS [patent_app_type] => utility [patent_app_number] => 16/265705 [patent_app_country] => US [patent_app_date] => 2019-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14047 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16265705 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/265705
COMPOSITIONS AND ASSAYS Jan 31, 2019 Abandoned
Array ( [id] => 18314152 [patent_doc_number] => 11628213 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-18 [patent_title] => Ichthyophthirius multifiliis vaccine system [patent_app_type] => utility [patent_app_number] => 16/963761 [patent_app_country] => US [patent_app_date] => 2019-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 33 [patent_no_of_words] => 17439 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963761 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/963761
Ichthyophthirius multifiliis vaccine system Jan 22, 2019 Issued
Array ( [id] => 16680737 [patent_doc_number] => 10940193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-09 [patent_title] => Controlled release vaccines and methods for treating [patent_app_type] => utility [patent_app_number] => 16/251757 [patent_app_country] => US [patent_app_date] => 2019-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 30 [patent_no_of_words] => 19058 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16251757 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/251757
Controlled release vaccines and methods for treating Jan 17, 2019 Issued
Array ( [id] => 14838891 [patent_doc_number] => 20190277846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-12 [patent_title] => BIOMARKERS OF LATENT TUBERCULOSIS INFECTION [patent_app_type] => utility [patent_app_number] => 16/246592 [patent_app_country] => US [patent_app_date] => 2019-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38517 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16246592 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/246592
Biomarkers of latent tuberculosis infection Jan 13, 2019 Issued
Array ( [id] => 14231275 [patent_doc_number] => 20190127810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-02 [patent_title] => SEQUENCE-SPECIFIC DETECTION AND PHENOTYPE DETERMINATION [patent_app_type] => utility [patent_app_number] => 16/245093 [patent_app_country] => US [patent_app_date] => 2019-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13881 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16245093 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/245093
Sequence-specific detection and phenotype determination Jan 9, 2019 Issued
Array ( [id] => 16290097 [patent_doc_number] => 10766933 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-08 [patent_title] => Mutated immunoglobulin-binding protein having increased alkaline tolerance [patent_app_type] => utility [patent_app_number] => 16/240074 [patent_app_country] => US [patent_app_date] => 2019-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9924 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16240074 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/240074
Mutated immunoglobulin-binding protein having increased alkaline tolerance Jan 3, 2019 Issued
Array ( [id] => 15813799 [patent_doc_number] => 10632056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-28 [patent_title] => Supplement to support healthy hair, skin, and nails [patent_app_type] => utility [patent_app_number] => 16/238592 [patent_app_country] => US [patent_app_date] => 2019-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6866 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16238592 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/238592
Supplement to support healthy hair, skin, and nails Jan 2, 2019 Issued
Array ( [id] => 16961426 [patent_doc_number] => 20210212925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => MAKE-UP COMPOSITION COMPRISING A HYDROLYSATE OF THEOBROMA CACAO L BEANS AND AT LEAST ONE PREBIOTIC AND A PROBIOTIC [patent_app_type] => utility [patent_app_number] => 16/956071 [patent_app_country] => US [patent_app_date] => 2018-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8423 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956071 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/956071
MAKE-UP COMPOSITION COMPRISING A HYDROLYSATE OF THEOBROMA CACAO L BEANS AND AT LEAST ONE PREBIOTIC AND A PROBIOTIC Dec 20, 2018 Pending
Array ( [id] => 16512813 [patent_doc_number] => 20200392071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-17 [patent_title] => Gene cluster for the biosynthetic production of tetracycline compounds in a heterologous host [patent_app_type] => utility [patent_app_number] => 16/954461 [patent_app_country] => US [patent_app_date] => 2018-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20119 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 940 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16954461 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/954461
Gene cluster for the biosynthetic production of tetracycline compounds in a heterologous host Dec 20, 2018 Abandoned
Array ( [id] => 16443671 [patent_doc_number] => 10835575 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-17 [patent_title] => Compositions and methods for treating disease using [patent_app_type] => utility [patent_app_number] => 16/227802 [patent_app_country] => US [patent_app_date] => 2018-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 23 [patent_no_of_words] => 17594 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16227802 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/227802
Compositions and methods for treating disease using Dec 19, 2018 Issued
Array ( [id] => 14468389 [patent_doc_number] => 20190185837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-20 [patent_title] => BOTULINUM TOXIN CELL BINDING DOMAIN POLYPEPTIDES AND METHODS OF USE FOR TREATMENTS OF FIBROSIS ASSOCIATED DISORDERS [patent_app_type] => utility [patent_app_number] => 16/228285 [patent_app_country] => US [patent_app_date] => 2018-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39925 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16228285 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/228285
BOTULINUM TOXIN CELL BINDING DOMAIN POLYPEPTIDES AND METHODS OF USE FOR TREATMENTS OF FIBROSIS ASSOCIATED DISORDERS Dec 19, 2018 Abandoned
Array ( [id] => 14464695 [patent_doc_number] => 20190183987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-20 [patent_title] => NEUROTOXINS FOR USE IN MINIMIZING SCARRING [patent_app_type] => utility [patent_app_number] => 16/224192 [patent_app_country] => US [patent_app_date] => 2018-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13562 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16224192 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/224192
NEUROTOXINS FOR USE IN MINIMIZING SCARRING Dec 17, 2018 Abandoned
Array ( [id] => 17421267 [patent_doc_number] => 11254709 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-22 [patent_title] => Method for promoting [patent_app_type] => utility [patent_app_number] => 16/220019 [patent_app_country] => US [patent_app_date] => 2018-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4230 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 218 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16220019 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/220019
Method for promoting Dec 13, 2018 Issued
Array ( [id] => 16468550 [patent_doc_number] => 20200370087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-26 [patent_title] => METHOD FOR DETERMINING MICROBIAL SUSCEPTIBILITY TO ANTIBIOTIC AGENTS [patent_app_type] => utility [patent_app_number] => 16/767722 [patent_app_country] => US [patent_app_date] => 2018-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10052 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16767722 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/767722
METHOD FOR DETERMINING MICROBIAL SUSCEPTIBILITY TO ANTIBIOTIC AGENTS Nov 29, 2018 Abandoned
Menu